Clinical and Molecular Evolution of an ALK-Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors

被引：2
|
作者：
Gene-Olaciregui, Nagore [1 ]
Perez-Somarriba, Marta [2 ,3 ]
Santa-Maria, Vicente [2 ]
Cruz, Ofelia [2 ]
Gomez-Gonzalez, Soledad [4 ]
Castaneda, Alicia [5 ]
Sunol, Mariona [6 ]
Rovira, Carlota [6 ]
Muchart, Jordi [7 ]
Hinojosa, Jose [8 ]
La Madrid, Andres Morales [2 ]
Lavarino, Cinzia [1 ,9 ]
机构：
[1] Hosp St Joan Deu, Pediat Canc Ctr Barcelona, Lab Mol Oncol, Barcelona, Spain
[2] Hosp St Joan Deu, Pediat Canc Ctr Barcelona, Neuro Oncol Unit, Barcelona, Spain
[3] Royal Marsden NHS Fdn Trust, Children & Young Peoples Unit, London, England
[4] Hosp St Joan Deu, Inst Recerca St Joan Deu, Pediat Canc Ctr Barcelona, Lab Dev Tumor Biol, Barcelona, Spain
[5] Hosp St Joan Deu, Pediat Canc Ctr Barcelona, Pediat Solid Tumor Unit, Barcelona, Spain
[6] Hosp St Joan Deu, Dept Pathol, Barcelona, Spain
[7] Hosp St Joan Deu, Dept Radiol, Barcelona, Spain
[8] Hosp St Joan Deu, Dept Neurosurg, Barcelona, Spain
[9] Barcelona Hosp, Pediat Canc Ctr, Lab Mol Oncol, C Santa Rosa 39-57, Barcelona 08950, Spain
来源：
JCO PRECISION ONCOLOGY | 2023年 / 7卷
关键词：
CENTRAL-NERVOUS-SYSTEM; ALECTINIB; CLASSIFICATION; CRIZOTINIB; CHILDREN; FUSION;
D O I：
10.1200/PO.22.00547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：7
相关论文
共 15 条
  • [1] ALK-DRIVEN INFANT-TYPE HEMISPHERIC HIGH-GRADE GLIOMA AND CNS HISTIOCYTOSIS SUCCESSFULLY TREATED WITH A SECOND GENERATION ALK-INHIBITOR: MOLECULAR CHARACTERIZATION SAVES THE DAY
    Chamdine, Omar
    Alotaibi, Rasees
    Alharbi, Qasim
    Altarrah, Hiba
    Abduljabbar, Lulwah
    Alzaher, Asrar
    Taha, Mahmoud
    Alsaiari, Sultan
    Alisawi, Wissam
    Alsadeq, Jalilah
    Abdulkader, Marwah
    Alhaddad, Fatima
    NEURO-ONCOLOGY, 2024, 26
  • [2] Outcomes of first, second, and third-generation anaplastic lymphoma kinase (ALK) inhibitors in non-small cell lung cancer brain metastases (NSCLCBM).
    Tatineni, Vineeth
    O'Shea, Patrick Joseph
    Rauf, Yasmeen
    Jia, Xuefei
    Murphy, Erin Sennett
    Chao, Samuel T.
    Suh, John H.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors ceritinib
    De Pas, Tommaso
    Pala, Laura
    Catania, Chiara
    Conforti, Fabio
    FUTURE ONCOLOGY, 2017, 13 (29) : 2629 - 2644
  • [4] A Retrospective Study of Non-Small Cell Lung Cancer Treated with Second- and Third-Generation EGFR Tyrosine Kinase Inhibitors
    Mitsuya, S.
    Tsuruoka, K.
    Kanaoka, K.
    Funamoto, T.
    Tsuji, H.
    Matsunaga, N.
    Nakamura, T.
    Tamura, Y.
    Imanishi, M.
    Ikeda, S.
    Fujisaka, Y.
    Goto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S596 - S596
  • [5] Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention
    Caocci, Giovanni
    Mulas, Olga
    Bonifacio, Massimiliano
    Abruzzese, Elisabetta
    Galimberti, Sara
    Orlandi, Ester Maria
    Iurlo, Alessandra
    Annunziata, Mario
    Luciano, Luigiana
    Castagnetti, Fausto
    Gozzini, Antonella
    Stagno, Fabio
    Binotto, Gianni
    Pregno, Patrizia
    Albano, Francesco
    Martino, Bruno
    Fozza, Claudio
    Scaffidi, Luigi
    Trawinska, Malgorzata Monika
    Barate, Claudia
    Elena, Chiara
    Cattaneo, Daniele
    Scalzulli, Emilia
    La Nasa, Giorgio
    Foa, Robin
    Breccia, Massimo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 288 : 124 - 127
  • [6] A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors
    Zulbaran-Rojas, Alejandro
    Lin, Huei-Kan
    Shi, Qiuling
    Williams, Loretta A.
    George, Binsah
    Garcia-Manero, Guillermo
    Jabbour, Elias
    O'Brien, Susan
    Ravandi, Farhad
    Wierda, William
    Estrov, Zeev
    Borthakur, Gautam
    Kadia, Tapan
    Cleeland, Charles
    Cortes, Jorge E.
    Kantarjian, Hagop
    CANCER MEDICINE, 2018, 7 (11): : 5457 - 5469
  • [7] Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer
    Bauman, Jessica R.
    Liu, Geoffrey
    Preeshagul, Isabel
    Liu, Stephen V.
    Melosky, Barbara
    Abrahami, Devin
    Li, Benjamin
    Thomaidou, Despina
    Duncan, Kirsten
    Krulewicz, Stan
    Rupp, Martin
    Lin, Jessica J.
    LUNG CANCER, 2024, 195
  • [8] Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma
    Lucas, Calixto-Hope G.
    Abdullaev, Zied
    Bruggers, Carol S.
    Mirchia, Kanish
    Whipple, Nicholas S.
    Alashari, Mouied M.
    Lowichik, Amy
    Cheshier, Samuel
    Phillips, Joanna J.
    Devine, Patrick
    Solomon, David A.
    Quezado, Martha
    Aldape, Kenneth D.
    Perry, Arie
    ACTA NEUROPATHOLOGICA, 2022, 143 (02) : 283 - 286
  • [9] Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma
    Calixto-Hope G. Lucas
    Zied Abdullaev
    Carol S. Bruggers
    Kanish Mirchia
    Nicholas S. Whipple
    Mouied M. Alashari
    Amy Lowichik
    Samuel Cheshier
    Joanna J. Phillips
    Patrick Devine
    David A. Solomon
    Martha Quezado
    Kenneth D. Aldape
    Arie Perry
    Acta Neuropathologica, 2022, 143 : 283 - 286
  • [10] Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors
    Olga Mulas
    Giovanni Caocci
    Fabio Stagno
    Massimiliano Bonifacio
    Mario Annunziata
    Luigiana Luciano
    Ester Maria Orlandi
    Elisabetta Abruzzese
    Nicola Sgherza
    Bruno Martino
    Francesco Albano
    Sara Galimberti
    Patrizia Pregno
    Monica Bocchia
    Fausto Castagnetti
    Mario Tiribelli
    Gianni Binotto
    Antonella Gozzini
    Isabella Capodanno
    Claudio Fozza
    Debora Luzi
    Fabio Efficace
    Maria Pina Simula
    Luigi Scaffidi
    Fiorenza De Gregorio
    Chiara Elena
    Malgorzata Monika Trawinska
    Daniele Cattaneo
    Imma Attolico
    Claudia Baratè
    Francesca Pirillo
    Anna Sicuranza
    Gabriele Gugliotta
    Rossella Stella
    Emilia Scalzulli
    Alessandra Iurlo
    Robin Foà
    Massimo Breccia
    Giorgio La Nasa
    Annals of Hematology, 2020, 99 : 1525 - 1530
12